Phase 2 Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults (18 years of age or older) are eligible to be considered.
- Both men and women are included.
- People who have been diagnosed with Parkinson's disease according to a specific set of international medical guidelines (MDS criteria, 2015).
- People who have lived with Parkinson's disease for at least 5 years.
- People who have been on a stable dose of the medications Levodopa and Carbidopa for the past 6 months.
- People who have been clinically diagnosed with dyskinesia (involuntary, uncontrolled movements that can occur as a side effect of Parkinson's medication).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose Parkinson's-like symptoms are caused by another underlying condition (known as secondary Parkinsonism).
- People who have an atypical form of a Parkinson's-like condition (a group of disorders that share some features with Parkinson's disease but are considered distinct conditions).
- People who currently have an active cancer diagnosis.
- People who are known to have had a bad reaction or allergy to a medication called cilostazol.
- People who are currently taking part in another clinical trial involving a treatment or intervention.
- People with significant liver problems (where liver enzyme levels are more than three times the accepted upper limit) or reduced kidney function (where kidney filtration rate is below a certain level — confirm with trial site).
- People who are currently taking warfarin, other blood-thinning medications, or anti-platelet drugs (medications that reduce clotting).
- People who have been diagnosed with congestive heart failure (a condition where the heart does not pump blood as effectively as it should).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201001103780
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Assessment of the severity of Parkinson's disease symptoms using the Movement Disorder Society-unified Parkinson's disease rating scale (MDS-UPDRS)Assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.